Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rex's thrombectomy system gets US OK

This article was originally published in Clinica

Executive Summary

The Cleaner rotational thrombectomy system developed by Rex Medical (Conshohocken, Pennsylvania) has received 510(k) clearance from the US FDA. The technology is designed for mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts. This is necessary in patients with end-stage renal disease (ESRD). The Cleaner technology is comprised of a disposable, battery operated hand held drive unit, which is attached to a wire and rotates at 4,000 RPM. Its radiopaque outer catheter allows the end user to navigate tortuous or thrombosed vascular access sites under fluoroscopy. Argon Medical Devices will lead all marketing and distribution efforts for Cleaner in the EU, the US and Canada. ESRD affects more than 1 in 1,000 persons in the US and is growing at a rate of 5-7% annually. There could be over 750,000 ESRD patients by 2020, more than 500,000 of whom could require haemodialysis.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel